“I am thrilled to join such an innovative company at the forefront of gene editing,” said Briggs Morrison, M.D. “I look forward to collaborating with the Board and the management team to drive CRISPR ...

Plus inc. (NASDAQ: PLUS) (news) today announced that Melissa Ballenger, Adjunct Professor at the Raymond A. Mason School of Business at William & Mary, has been appointed as a member of its Board of ...